Fly News Breaks for March 12, 2015
PTX
Mar 12, 2015 | 06:48 EDT
Cantor Fitzgerald downgraded Pernix Therapeutics to Hold citing commercial execution risk following the company's acquisition of Zogenix's Zohydro ER franchise. Cantor lowered its price target for shares to $11 from $12.
News For PTX From the Last 2 Days
There are no results for your query PTX